Boston Scientific to Acquire Preventice Solutions for $925 Million

January 22, 2021

Boston Scientific entered into a definitive agreement to acquire Preventice Solutions, a private provider of mobile cardiac health monitoring solutions and services, for an upfront cash payment of $925 million. The deal also includes up to $300 million in potential commercial milestone payments and is expected to close by mid-2021 subject to customary conditions.

Buyers
Boston Scientific
Targets
Preventice Solutions
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.